Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (461-470 of 522) with videos related to

Pageof 53
Sort By:
Prostate Cancer and Prostatic Diseases|March 8, 2023
Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancerJacob E Tallman, Christopher J D Wallis, Zhiguo Zhao, et al.
The Journal of Urology|December 19, 2017
The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR StudySvetlana Avulova, Zhiguo Zhao, Daniel Lee, et al.
JNCI Cancer Spectrum|October 18, 2022
The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate CancerDaniel D Joyce, Christopher J D Wallis, Li-Ching Huang, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)Lisa F Newcomb, Yingye Zheng, Anna V Faino, et al.
The Journal of Urology|April 29, 2020
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance StudyMichael A Liss, Lisa F Newcomb, Yingye Zheng, et al.
Prostate Cancer and Prostatic Diseases|August 29, 2019
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillanceAnnika Herlemann, Huei-Chung Huang, Ridwan Alam, et al.
Urology|February 13, 2017
The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based CohortMaximilian F Lang, Mark D Tyson, JoAnn Rudd Alvarez, et al.
The Journal of Urology|June 20, 2019
Interpretation of Domain Scores on the EPIC-How Does the Domain Score Translate into Functional Outcomes?Aaron A Laviana, Agustin Hernandez, Li-Ching Huang, et al.
Cancers|April 30, 2021
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional StudyMartina Maggi, Francesco Del Giudice, Ugo G Falagario, et al.
Urologic Oncology|June 22, 2021
Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohortChristopher J D Wallis, Li-Ching Huang, Zhiguo Zhao, et al.
Pageof 53

Showing results (461-470 of 522) with videos related to

Sort By:
Pageof 53
Prostate Cancer and Prostatic Diseases|March 8, 2023
Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancerJacob E Tallman, Christopher J D Wallis, Zhiguo Zhao, et al.
The Journal of Urology|December 19, 2017
The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR StudySvetlana Avulova, Zhiguo Zhao, Daniel Lee, et al.
JNCI Cancer Spectrum|October 18, 2022
The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate CancerDaniel D Joyce, Christopher J D Wallis, Li-Ching Huang, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)Lisa F Newcomb, Yingye Zheng, Anna V Faino, et al.
The Journal of Urology|April 29, 2020
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance StudyMichael A Liss, Lisa F Newcomb, Yingye Zheng, et al.
Prostate Cancer and Prostatic Diseases|August 29, 2019
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillanceAnnika Herlemann, Huei-Chung Huang, Ridwan Alam, et al.
Urology|February 13, 2017
The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based CohortMaximilian F Lang, Mark D Tyson, JoAnn Rudd Alvarez, et al.
The Journal of Urology|June 20, 2019
Interpretation of Domain Scores on the EPIC-How Does the Domain Score Translate into Functional Outcomes?Aaron A Laviana, Agustin Hernandez, Li-Ching Huang, et al.
Cancers|April 30, 2021
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional StudyMartina Maggi, Francesco Del Giudice, Ugo G Falagario, et al.
Urologic Oncology|June 22, 2021
Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohortChristopher J D Wallis, Li-Ching Huang, Zhiguo Zhao, et al.
Pageof 53